Advertise X LinkedIn

Dow Jones 50,978.09 ▼0.39%S&P 500 7,775.63 ▼0.34%Nasdaq 27,402.16 ▼0.50%Russell 2000 2,767.33 ▼0.93%S&P/TSX 34,999.45 ▼0.12%Bovespa 206,150.31 ▲0.90%DAX 24,827.57 ▼1.10%FTSE 100 10,439.93 ▼0.18%CAC 40 7,732.62 ▼0.47%Euro Stoxx 50 6,134.88 ▼0.73%IBEX 35 18,974.00 ▼0.75%FTSE MIB 49,366.24 ▼1.21%Nikkei 225 69,042.11 ▼1.42%Shanghai 3,811.90 ▼0.79%Hang Seng 23,785.79 ▼1.43%KOSPI 6,625.93 ▼2.62%Nifty 50 22,231.80 ▼1.64%ASX 200 8,660.90 ▼0.77%AAPL 337.84 ▲0.35%NVDA 236.23 ▼0.52%MSFT 530.50 ▲0.14%GOOGL 350.79 ▲0.08%AMZN 258.64 ▼0.49%META 721.47 ▲0.02%TSLA 372.38 ▼1.44%JPM 326.73 ▼0.87%BTC 81,538.00 ▼1.76%ETH 2,470.02 ▼3.49%SOL 109.38 ▼5.72%EUR/USD 1.1199 ▲0.04%USD/INR 96.78 ▲0.02%GOLD 4,138.20 ▼0.06%CRUDE 93.08 ▲5.44%Dow Jones 50,978.09 ▼0.39%S&P 500 7,775.63 ▼0.34%Nasdaq 27,402.16 ▼0.50%Russell 2000 2,767.33 ▼0.93%S&P/TSX 34,999.45 ▼0.12%Bovespa 206,150.31 ▲0.90%DAX 24,827.57 ▼1.10%FTSE 100 10,439.93 ▼0.18%CAC 40 7,732.62 ▼0.47%Euro Stoxx 50 6,134.88 ▼0.73%IBEX 35 18,974.00 ▼0.75%FTSE MIB 49,366.24 ▼1.21%Nikkei 225 69,042.11 ▼1.42%Shanghai 3,811.90 ▼0.79%Hang Seng 23,785.79 ▼1.43%KOSPI 6,625.93 ▼2.62%Nifty 50 22,231.80 ▼1.64%ASX 200 8,660.90 ▼0.77%AAPL 337.84 ▲0.35%NVDA 236.23 ▼0.52%MSFT 530.50 ▲0.14%GOOGL 350.79 ▲0.08%AMZN 258.64 ▼0.49%META 721.47 ▲0.02%TSLA 372.38 ▼1.44%JPM 326.73 ▼0.87%BTC 81,538.00 ▼1.76%ETH 2,470.02 ▼3.49%SOL 109.38 ▼5.72%EUR/USD 1.1199 ▲0.04%USD/INR 96.78 ▲0.02%GOLD 4,138.20 ▼0.06%CRUDE 93.08 ▲5.44%

PACB

Stocks · Aug 17, 2026
PacBio Cuts Revenue Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity

PacBio cuts 2026 outlook as SPRQ-Nx transition lags, targets 2028 cash-flow positivity. Q2 revenue hit $39M amid restructuring and cost cuts.

PacBio long-read sequencing instrument in a modern laboratory setting